Stay updated on Pembrolizumab Combo Clinical Trial in Advanced NSCLC
Sign up to get notified when there's something new on the Pembrolizumab Combo Clinical Trial in Advanced NSCLC page.

Latest updates to the Pembrolizumab Combo Clinical Trial in Advanced NSCLC page
- Check2 days agoChange DetectedA new revision entry labeled v3.5.4 is added to the history, replacing the previous v3.5.3 entry. This reflects an update to the record's versioning in the study history.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page's revision line now shows v3.5.3, replacing the previous v3.5.2, signaling a new frontend deployment for this page.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe record history shows Revision: v3.5.2 replacing Revision: v3.5.0.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision: v3.5.0 has been added to the history and Revision: v3.4.3 has been removed.SummaryDifference0.0%

- Check59 days agoChange DetectedThe study page now includes the Study Status and Contacts/Locations sections, and the 2026-02-27 entry was removed.SummaryDifference0.2%

- Check66 days agoChange DetectedRevision v3.4.3 added and revision v3.4.2 removed from the page history.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo Clinical Trial in Advanced NSCLC
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo Clinical Trial in Advanced NSCLC page.